Completed PHASE2 INTERVENTIONAL 1-arm NCT02606916

Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.

A Prospective, Single-arm Study of Simultaneous Modulated Accelerated Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Carcinoma.

Sponsor: Sun Yat-sen University

Conditions Esophageal Squamous Cell Carcinoma

Interventions DDP S-1 SMART

Updated 7 times since 2017 Last updated: Sep 2, 2020 Started: Jul 31, 2015 Primary completion: Aug 31, 2020 Completion: Aug 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Esophageal Squamous Cell Carcinoma and is currently completed. Sun Yat-sen University leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Oct 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed
May 2019 — Oct 2020 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

Jun 2018 — May 2019 [monthly]

Recruiting PHASE2
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China